Diversinet unveils MobiHealth Wallet
Diversinet has launched the MobiHealth Wallet, an application that patients can use to download their personal health records to their smartphones using the federal Blue Button web tool so they can share them with their doctors.
Diversinet announced the MobiHealth Wallet at the Health Summit in National Harbor on December 3. Blue Button allows the patients to download their personal health information as a PDF or text file.
The Blue Button is being adopted by the federal agencies, healthcare providers, payers and pharmacy chains.
The MobiHealth wallet provides an interoperable framework for patients to manage, store and share their health data from their personal health portal with many providers.
It also allows doctors, case workers and the patients to share data and engage on the mobile devices through email, text messages and voice calls.
This Diversinet tool can create and edit profiles that include their health lifestyle preferences. The doctors use the profiles along with the information from medication adherence and mood-tracker tools to study patients’ health patterns.
“The goal of the MobiHealth Wallet is to understand how patients change their health behaviors, said, Dr. Hon Pak, Diversinet’s CEO. The MobiHealth Wallet links with Diversinet’s web-based portal, which stores a copy of patients’ PHR data.
For the medical data to be shared by providers, the health companies are presently forming health information exchanges, but the Diversinet MobiHealth Wallet is way of sharing more lifestyle data found in patients’ PHRs.
Mr. Pak also said, “We’re providing patient-centric data interoperability to help providers not in the network or not in the same system to have access to the data through the wallet in ways that have not have been possible.”
The MobiHealth wallet is available on all mobile OS platforms, including iOS, Android and Windows Phone.
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”